Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Neuropediatrics
|
November 24, 1999
Physical map of the region surrounding the ataxia-telangiectasia gene on human chromosome 11q22-23
N S Udar, S Xu, J O Bay, et al.
Breast Cancer Research and Treatment
|
April 6, 2012
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition
E Rouleau, B Jesson, A Briaux, et al.
International Journal of Radiation Biology
|
December 1, 1994
Genetic haplotyping of ataxia-telangiectasia families localizes the major gene to an approximately 850 kb region on chromosome 11q23.1
R A Gatti, E Lange, G Rotman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact
J M Nabholtz, C Abrial, M A Mouret-Reynier, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Neuropediatrics
|
November 24, 1999
Physical map of the region surrounding the ataxia-telangiectasia gene on human chromosome 11q22-23
N S Udar, S Xu, J O Bay, et al.
Breast Cancer Research and Treatment
|
April 6, 2012
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition
E Rouleau, B Jesson, A Briaux, et al.
International Journal of Radiation Biology
|
December 1, 1994
Genetic haplotyping of ataxia-telangiectasia families localizes the major gene to an approximately 850 kb region on chromosome 11q23.1
R A Gatti, E Lange, G Rotman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact
J M Nabholtz, C Abrial, M A Mouret-Reynier, et al.
Page
of 3